West Pharmaceutical
590 hedge funds and large institutions have $19.3B invested in West Pharmaceutical in 2021 Q1 according to their latest regulatory filings, with 78 funds opening new positions, 221 increasing their positions, 201 reducing their positions, and 76 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 221 | Existing positions reduced: 201
3% more first-time investments, than exits
New positions opened: 78 | Existing positions closed: 76
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
0.04% less ownership
Funds ownership: 93.08% → 93.04% (-0.04%)
1% less funds holding
Funds holding: 593 → 590 (-3)
1% less capital invested
Capital invested by funds: $19.4B → $19.3B (-$169M)
24% less call options, than puts
Call options by funds: $19M | Put options by funds: $25M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APG Asset Management
Amsterdam,
Netherlands
|
+$329M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$111M |
| 3 |
ProShare Advisors
Bethesda,
Maryland
|
+$107M |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$77.3M |
| 5 |
BlackRock
New York
|
+$50.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$94.6M |
| 2 |
Neuberger Berman Group
New York
|
-$85.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$77.4M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$68.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$61M |
WST Hedge Fund Activity: Q1 2021 in Review
590 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q1 2021, worth a combined $19.3B — down 0.87% from $19.4B a quarter earlier.
Buyers outnumbered sellers: 78 funds opened new WST positions and 76 closed out — a net gain of 2 holders — while 221 added to existing stakes and 201 trimmed.
The largest buyer was APG Asset Management, adding an estimated $329M. The largest seller was AllianceBernstein, cutting an estimated $94.6M.
- 590 institutional investors held West Pharmaceutical (WST) as of Q1 2021, down from 593 in Q4 2020.
- Funds reported $19.3B of West Pharmaceutical stock for Q1 2021, down 0.87% quarter-over-quarter.
- 78 funds opened new West Pharmaceutical positions in Q1 2021 and 76 closed out, a net change of +2 holders.
- The largest West Pharmaceutical buyer in Q1 2021 was APG Asset Management, an estimated $329M added.
- The largest West Pharmaceutical seller in Q1 2021 was AllianceBernstein, an estimated $94.6M sold.
Based on aggregated 13F filings for Q1 2021.